Citation: Kc. Herold et al., EXPRESSION AND IMMUNE-RESPONSE TO ISLET ANTIGENS FOLLOWING TREATMENT WITH LOW-DOSES OF STREPTOZOTOCIN IN H-2(D) MICE, Journal of autoimmunity, 10(1), 1997, pp. 17-25
Authors:
HEROLD KC
VEZYS V
KOONS A
LENSCHOW D
THOMPSON C
BLUESTONE JA
Citation: Kc. Herold et al., CD28 B7 COSTIMULATION REGULATES AUTOIMMUNE DIABETES-INDUCED WITH MULTIPLE LOW-DOSES OF STREPTOZOTOCIN/, The Journal of immunology, 158(2), 1997, pp. 984-991
Authors:
HEROLD KC
LU J
RULIFSON I
VEZYS V
TAUB D
GRUSBY MJ
BLUESTONE JA
Citation: Kc. Herold et al., REGULATION OF C-C CHEMOKINE PRODUCTION BY MURINE T-CELLS BY CD28 B7 COSTIMULATION/, The Journal of immunology, 159(9), 1997, pp. 4150-4153
Authors:
HEROLD KC
VEZYS V
SUN Q
VIKTORA D
SEUNG E
REINER S
BROWN DR
Citation: Kc. Herold et al., REGULATION OF CYTOKINE PRODUCTION DURING DEVELOPMENT OF AUTOIMMUNE DIABETES-INDUCED WITH MULTIPLE LOW-DOSES OF STREPTOZOTOCIN, The Journal of immunology, 156(9), 1996, pp. 3521-3527
Citation: Kc. Herold et al., DIABETES-INDUCED WITH LOW-DOSES OF STREPTOZOTOCIN IS MEDIATED BY V-BETA-8.2(-CELLS() T), Diabetes, 44(3), 1995, pp. 354-359
Citation: Kc. Herold et al., AUTOIMMUNE DIABETES WITH LOW-DOSES OF STREPTOZOTOCIN IS MEDIATED BY V-BETA-8.2-CELLS( T), Diabetes, 43, 1994, pp. 10000117-10000117
Citation: Kc. Herold et al., PREVENTION OF AUTOIMMUNE DIABETES BY TREATMENT WITH ANTI-LFA-1 AND ANTI-ICAM-1 MONOCLONAL-ANTIBODIES, Clinical research, 42(2), 1994, pp. 10000119-10000119
Citation: Kc. Herold et al., PREVENTION OF AUTOIMMUNE DIABETES BY TREATMENT WITH ANTI-LFA-1 AND ANTI-ICAM-1 MONOCLONAL-ANTIBODIES, Cellular immunology, 157(2), 1994, pp. 489-500